Sanofi Teams With U.S. Military on Zika Vaccine Development
- Reed Institute to transfer vaccine technology to Sanofi
- Sanofi responsible for vaccine production, clinical strategy
This article is for subscribers only.
Sanofi will partner with the U.S Walter Reed Army Institute of Research to develop a Zika vaccine candidate using an inactivated version of the virus.
Walter Reed, a military biomedical research institute within the Department of Defense, will transfer its purified inactivated virus vaccine technology to Sanofi’s vaccines division. The Paris-based drugmaker will be responsible for handling human trials, improving production yields, and creating a clinical and regulatory strategy, according to a statement Wednesday.